Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Novo Nordisk's Ozempic Pill Fails to Slow Alzheimer's, Amazon Rises, Tesla Jumps | Stock Movers
Posted
November 24, 2025
Views
122
Likes
1
Engagement
0.82%
November 24, 2025
122
1
0.82%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
4:51Now PlayingOn this episode of Stock Movers:
- Novo Nordisk (NVO) dropped after a pill version of Ozempic failed to slow the progression of Alzheimer’s disease in a pair of long-shot studies that aimed to open up a new use for blockbuster obesity drugs.
- Amazon (AMZN) is rising. The company says it will spend as much as $50 billion, expanding its capacity to provide artificial intelligence and high-performance computing services to US government entities.
- Tesla (TSLA) shares jumped around 7% on Monday after a Sunday post on X from Elon Musk commenting on the company’s AI chip plans.
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Novo Nordisk's Ozempic Pill Fails to Slow Alzheimer's, Amazon Rises, Tesla Jumps
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
